Geetha Subramaniam - Concepedia

Author

Geetha Subramaniam

Also Known As

G. Subramaniam, G.A. Subramaniam, GEETHA SUBRAMANIAM, Gandhi Doss Subramaniam, Geetha A Subramaniam, Geetha A. Subramaniam, Geetha Subramaniam, Subramaniam. G

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

National Institute on Drug Abuse Johns Hopkins University Friends Research Institute Duke University New York University

About

Geetha Subramaniam is an author at National Institute on Drug Abuse specializing in addiction, medicine, and addiction medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.5K
2	Health Sciences	12	12	1.3K
3	Public Health	8	8	501
4	Education	2	2	63
5	Nursing	1	1	25

Geetha Subramaniam

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial Joshua D. Lee, Edward V. Nunes, Patricia Novo, The Lancet Opioid EpidemicComparative EffectivenessSubstance AbuseOpioid Relapse PreventionAddiction Treatment	2017	681
Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth George Woody, Sabrina Poole, Geetha Subramaniam, JAMA	2008	351
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients Jennifer McNeely, Li‐Tzy Wu, Geetha Subramaniam, Annals of Internal Medicine	2016	291
Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients William S. John, He Zhu, Paolo Mannelli, Drug and Alcohol Dependence Family MedicineSubstance AbusePrimary CareSubstance UsePsychiatry	2018	126
Randomized Controlled Trial of Osmotic-Release Methylphenidate With Cognitive-Behavioral Therapy in Adolescents With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders Paula Riggs, Theresa Winhusen, Robert D. M. Davies, Journal of the American Academy of Child & Adolescent Psychiatry Osmotic-release MethylphenidateAdhdPsychopathologySubstance UsePsychiatry	2011	125
Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder Geetha Subramaniam, Maxine Stitzer Drug and Alcohol Dependence Opioid EpidemicSubstance AbuseSubstance UsePsychiatryAddiction Treatment	2008	95
Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case‐series and feasibility Marc Fishman, Erin L. Winstanley, Erin M. Curran, Addiction	2010	85
Cost‐effectiveness of extended buprenorphine–naloxone treatment for opioid‐dependent youth: data from a randomized trial Daniel Polsky, Henry A. Glick, Jianing Yang, Addiction	2010	77
Perceived academic benefit is associated with nonmedical prescription stimulant use among college students Amelia M. Arria, Irene M. Geisner, M. Dolores Cimini, Addictive Behaviors Substance AbuseStudent RetentionSubstance UsePsychiatryHealth Policy	2017	75
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care Jan Gryczynski, Jennifer McNeely, Li‐Tzy Wu, Journal of General Internal Medicine Health ConditionsSubstance AbusePrimary CareSubstance UseHealth Policy	2017	74

Page 1